Download: Drugs Act - Notifications

Govt. of India issues Notifications time to time which are published by the Department of Publication and are printed by the Government of India Printing Presses regularly.

We have provided some of the notifications relevant to the above-said topic, Click on the below links for more information:

2022

S.O. 5090(E) dt 02-11-2022 Appointment of Smt. G Sasikala, Shri Kishore, Smt. Rimjhim as Govt Analyst at CDTL Chennai - Drugs and Cosmetics Act 1940

S.O.-5090E-dt-02-11-2022-Appointment-of-Smt.-G-Sasikala-Shri-Kishore-Smt.-Rimjhim-as-Govt-Analyst-at-CDTL-Chennai-Drugs-and-Cosmetics-Act-1940

S.O. 3758(E) dt 10-08-2022 To authorize director incharge Dr. Saroj Kumar Ghosh of CDL Kolkata for signing report of test of MD samples sent by Court of Laws.

S.O.-3758E-dt-10-08-2022-To-authorize-director-incharge-Dr.-Saroj-Kumar-Ghosh-of-CDL-Kolkata-for-signing-report-of-test-of-MD-samples-sent-by-Court-of-Laws.

S.O. 3757(E) dt 10-08-2022 Notification of Director Incharge Dr Saroj Kumar Ghosh of CDL Kolkata

S.O.-3757E-dt-10-08-2022-Notification-of-Director-Incharge-Dr-Saroj-Kumar-Ghosh-of-CDL-Kolkata

S.O. 3739(E) dt 02-08-2022 Notification of Medical Devices Testing Officer for CMDTL

S.O.-3739E-dt-02-08-2022-Notification-of-Medical-Devices-Testing-Officer-for-CMDTL

Ministry of Health Dt 08-07-2022 Draft of New Drugs, Medical Devices, and Cosmetics Bill 2022

Ministry-of-Health-Dt-08-07-2022-Draft-of-New-Drugs-Medical-Devices-and-Cosmetics-Bill-2022

2021

S.O. 5139(E) dt 10-12-2021 Renotification of NIB Noida as CDL for testing of COVID 19 vaccine Section 6 and 26 B of Drugs and Cosmetics Act

S.O.-5139E-dt-10-12-2021-Renotification-of-NIB-Noida-as-CDL-for-testing-of-COVID-19-vaccine-Section-6-and-26-B-of-Drugs-and-Cosmetics-Act

GSR 767(E) dt 27-10-2021 Draft - to amend rule 2 to substitute cell or stem cell-derived product under New Drugs and Clinical Trial Rules 2019

GSR-767E-dt-27-10-2021-Draft-to-amend-rule-2-to-substitute-cell-or-stem-cell-derived-product-under-NDCTR-2019

GSR 762(E) dt 27-10-2021 - Sec 10 of D&C Act - To allow the import of Oxytocin API for the manufacture of formulation for export purpose only

GSR-762E-dt-27-10-2021-Sec-10-of-DC-Act-To-allow-import-of-Oxytocin-API-for-manufacture-of-formulation-for-export-purpose-only

S.O. 4326(E) dt 18-10-2021 - Section 5 of D&C Act Reconstitution of DTAB

S.O.-4326E-dt-18-10-2021-Section-5-of-DC-Act-Reconstitution-of-DTAB

GSR 668(E) dt 23-09-2021 - Draft Amendment addition of Homoeopathic System in the First Schedule of D&C Act

GSR-668E-dt-23-09-2021-Draft-Amendment-addition-of-Homoeopathic-System-in-the-First-Schedule-of-DC-Act

S.O. 1521(E) dt 08-04-2021 Notification of 5 officers at CDTL, Mumbai as Government Analysts under section 20(2) of the Drugs and Cosmetics Act, 1940

S.O.-1521E-dt-08-04-2021-Notification-of-5-officers-at-CDTL-Mumbai-as-Government-Analysts-under-section-202-of-the-Drugs-and-Cosmetics-Act-1940

S.O. 1520(E) dt 07-04-2021 Notification of officer at CDTL, Hyderabad as Government Analyst under section 20(2) of the Drugs and Cosmetics Act, 1940

S.O.-1520E-dt-07-04-2021-Notification-of-officer-at-CDTL-Hyderabad-as-Government-Analyst-under-section-202-of-the-Drugs-and-Cosmetics-Act-1940

GSR 255(E) dt 07-04-2021 Exclusion of FDC of Tamsulosin and Deflazacort from banned list of drugs

GSR-255E-dt-07-04-2021-Exclusion-of-FDC-of-Tamsulosin-and-Deflazacort-from-banned-list-of-drugs

S.O.1260(E) dt 19-03-2021 Notification of Debasis Maitti and Hitesh Khare as Govt. Analysts at RDTL Chandigarh

S.O.1260E-dt-19-03-2021-Notification-of-Debasis-Maitti-and-Hitesh-Khare-as-Govt.-Analysts-at-RDTL-Chandigarh

S.O. 1170(E) dt 12-03-2021 Notification Amar jyoti, Dilip Kr, Rinku & Arun Kr at RDTL Guwahati as Govt. analyst

S.O.-1170E-dt-12-03-2021-Notification-Amar-jyoti-Dilip-Kr-Rinku-Arun-Kr-at-RDTL-Guwahati-as-Govt.-analyst

2020

S.O. 2451 (E) dt 20-07-2020 - Sec 26B - Exemption of sale license for sanitizers

S.O.-2451-E-dt-20-07-2020-Sec-26B-Exemption-of-sale-license-for-sanitizers

GSR-No-220 (E) dt. 26-03-2020 Regarding door step delivery of medicine

GSR-No-220-E-dt-26-03-2020-regarding-door-step-delivery-of-medicines

GSR-219 (E) dt 26-03-2020 Regarding Hydroxychloroquine is Schedule-H 1 drug now

GSR-219-E-dt-26-03-2020-Hydroxychloroquine-is-Schedule-H-1-drug-now

G.S.R.-52 (E) dt. 27-01-2020 Exemption of Import of Oxytocin reference standards from Prohibition

G.S.R.-52E-27-01-2020-Exemption-of-Import-of-Oxytocin-reference-standards-from-Prohibition

2019

GSR 4271(E) dt 26-11-2019 - 12 Govt Analyst notified for the whole of India

GSR-4271E-dt-26-11-2019-12-Govt-Analyst-notified-for-the-whole-of-India

G.S.R. No. 827 (E) dt. 06-11-19 Draft Notification Sch-K

G.S.R.-No.-827E-dt.-06-11-19-Draft-Notification-Sch-K

S.-O.-1500 (E) dt. 02-04-2019 Organ preservative solution as drug

S.-O.-1500-E-dt.-02-04-2019-Organ-preservative-solution-as-drug

2018

GSR 794(E) dt 21-08-2018 Mfg of Oxytocin Formulation by Public Sector 26A of D&C Act

GSR-794E-dt-21-08-2018-Mfg-of-Oxytocin-Formulation-by-Public-Sector-26A-of-DC-Act

S.O.-3400-E-dt.-11-07-18-Medical-devices-MDTO

S.O.-3400-E-dt.-11-07-18-Medical-devices-MDTO

GSR 411(E) dt 27.04.2018 - Manufacture Prohibition of Oxytocin with conditions under Section 26A of D&C Act

GSR-411E-dt-27.04.2018-Manufacture-Prohibition-of-Oxytocin-with-conditions-under-Section-26A-of-DC-Act

GSR 390(E) dated 24.04.2018 Import banning of Oxytocin under Section 10A D&C Act

GSR-390E-dated-24.04.2018-Import-banning-of-Oxytocin-under-Section-10A-DC-Act

2015

GSR 2393(E) dt 02-09-2015 - 5 Govt Analyst notified for the whole of India

GSR-2393E-dt-02-09-2015-5-Govt-Analyst-notified-for-the-whole-of-India

2012

S.O. 2809(E) dt 30-11-2012 Appointment of Smt. C Vijaya, Smt. J Uma as Govt Analyst at CDTL Chennai - Drugs and Cosmetics Act 1940

S.O.-2809E-dt-30-11-2012-Appointment-of-Smt.-C-Vijaya-Smt.-J-Uma-as-Govt-Analyst-at-CDTL-Chennai-Drugs-and-Cosmetics-Act-1940

S.O. 2808(E) dt 30-11-2012 Appointment of Smt. Mansi, Smt. Sayati as Govt Analyst at CDTL Mumbai - Drugs and Cosmetics Act 1940

S.O.-2808E-dt-30-11-2012-Appointment-of-Smt.-Mansi-Smt.-Sayati-as-Govt-Analyst-at-CDTL-Mumbai-Drugs-and-Cosmetics-Act-1940

2011

GSR 2213(E) dt 26-09-2011 - 2 Govt Analyst notified for the whole of India in NIB Noida

GSR-2213E-dt-26-09-2011-2-Govt-Analyst-notified-for-the-whole-of-India-in-NIB-Noida

S.O. 722(E) dt 08-04-2011 - Section 5 - Constitution of DTAB - Drugs and Cosmetics Act

S.O.-722E-dt-08-04-2011-Section-5-Constitution-of-DTAB-Drugs-and-Cosmetics-Act

2009

GSR 738(E) dt 09-10-2009 Amendment in the notification number G.S.R. 578(E), 23rd July, 1983 Substitutes FDC of Corticosteroid with any other drug for internal use

GSR-738E-dt-09-10-2009-Amendment-in-the-notification-number-G.S.R.-578E-23rd-July-1983-Substitutes-FDC-of-Corticosteroid-with-any-other-drug-for-internal-use

2008

Drugs and Cosmetics (Amendment) Act No. 26 of 2008

Drugs-and-Cosmetics-Amendment-Act-No.-26-of-2008

For Drugs Rules notifications, click here
https://thehealthmaster.com/notifications/drugs-act-notifications/